Phase I/II Study of Weekly Oraxol for the Second-Line Treatment of Patients With Metastatic or Recurrent Gastric Cancer

LESSONS LEARNED: Oraxol, a novel oral formulation of paclitaxel, displayed modest efficacy as second-line chemotherapy for gastric cancer. Considering its favorable toxicity profiles, further studies are warranted in various solid tumors including gastric cancer. BACKGROUND. Oraxol consists of pacli...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Lee, Keun-Wook, Lee, Kyung Hee, Zang, Dae Young, Park, Young Iee, Shin, Dong Bok, Kim, Jin Won, Im, Seock-Ah, Koh, Sung Ae, Yu, Kyung-Sang, Cho, Joo-Youn, Jung, Jin-A, Bang, Yung-Jue
Materialtyp: Artigo
Språk:Inglês
Publicerad: AlphaMed Press 2015
Ämnen:
Clinical Trial Results
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4524762/
https://ncbi.nlm.nih.gov/pubmed/26112004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0202
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk